Richard G. Horan

Vorstandsvorsitzender bei

Gila Therapeutics, Inc.

Finance

Health Technology

Consumer Services

Profil

Richard G.
Horan is the founder of Sachem Ventures, founded in 1998.
Mr. Horan is currently the Chief Executive Officer & Director at Gila Therapeutics, Inc. and Director at GenEncap, Inc. Former positions include President & CEO at SEQ Ltd. from 1992 to 1997, Senior Managing Director at Slater Technology Fund, Inc. from 2002 to 2017, and Director roles at Bionica Corp., CytoSolv, Inc., Cadent Therapeutics, Inc., Medley Genomics, Inc., and Mindimmune Therapeutics, Inc. Formerly a Partner at Johnston Associates, Inc. from 1986 to 1997 and Principal at Bank of America Private Bank from 1980 to 1985.
Education includes undergraduate and graduate degrees from Dartmouth College.

Aktive Positionen von Richard G. Horan

Unternehmen	Position	Beginn
GenEncap, Inc. GenEncap, Inc. Medical SpecialtiesHealth Technology Develops and commercializes DNA sequencing technology	Direktor/Vorstandsmitglied	24.04.2012
Gila Therapeutics, Inc. Gila Therapeutics, Inc. Other Consumer ServicesConsumer Services Provides developing therapies for obesity patients	Vorstandsvorsitzender	-

Alle aktiven Positionen von Richard G. Horan

Ehemalige bekannte Positionen von Richard G. Horan

Unternehmen	Position	Ende
Slater Technology Fund, Inc. Slater Technology Fund, Inc. Investment ManagersFinance Slater Technology Fund invests in companies located in the United States. The firm targets companies operating in the fields of software, technology, energy and life sciences sectors. It provides financing for seed and early stage capital requirements.	Private Equity Investor	01.01.2017
Johnston Associates, Inc. Johnston Associates, Inc. Investment ManagersFinance Johnston Associates invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed, early and later stage transactions.	Corporate Officer/Principal	31.12.1997
SEQ Ltd.	Vorstandsvorsitzender	01.12.1997
Bank of America Private Bank Bank of America Private Bank Investment ManagersFinance The foundation of BAPB's equity selection process is proprietary research. They use a blend of qualitative and quantitative fundamental research to target large capitalization companies that have long-term growth potential, proven earnings track records, competitive advantages and strong management. Fixed-income investments are tailored to address client-specific needs for income and capital appreciation.	Corporate Officer/Principal	31.12.1985
Medley Genomics, Inc. Medley Genomics, Inc. Internet Software/ServicesTechnology Services Provides genomic analysis services to cancer patients through genome mapping platform	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Richard G. Horan im Detail an

Ausbildung von Richard G. Horan

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Richard G. Horan im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Dartmouth College Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Johnston Associates, Inc. Johnston Associates, Inc. Investment ManagersFinance Johnston Associates invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed, early and later stage transactions.	Finance
Bank of America Private Bank Bank of America Private Bank Investment ManagersFinance The foundation of BAPB's equity selection process is proprietary research. They use a blend of qualitative and quantitative fundamental research to target large capitalization companies that have long-term growth potential, proven earnings track records, competitive advantages and strong management. Fixed-income investments are tailored to address client-specific needs for income and capital appreciation.	Finance
Slater Technology Fund, Inc. Slater Technology Fund, Inc. Investment ManagersFinance Slater Technology Fund invests in companies located in the United States. The firm targets companies operating in the fields of software, technology, energy and life sciences sectors. It provides financing for seed and early stage capital requirements.	Finance
GenEncap, Inc. GenEncap, Inc. Medical SpecialtiesHealth Technology Develops and commercializes DNA sequencing technology	Health Technology
Sachem Ventures Sachem Ventures Investment ManagersFinance Sachem Ventures invest in companies located in the United States, primarily in New Haven. The firm targets companies operating across a broad range of sectors. It provides financing for early stage transactions with a investment size of USD 0.075 - 0.125 million. The firm does not invest in real estate.	Finance
Bionica Corp. Bionica Corp. Specialty TelecommunicationsCommunications Develops personal communication systems for the hearing-impaired people	Communications
CytoSolv, Inc. CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology Develops proprietary technology to address wound healing	Health Technology
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders	Health Technology
SEQ Ltd.
Gila Therapeutics, Inc. Gila Therapeutics, Inc. Other Consumer ServicesConsumer Services Provides developing therapies for obesity patients	Consumer Services
Medley Genomics, Inc. Medley Genomics, Inc. Internet Software/ServicesTechnology Services Provides genomic analysis services to cancer patients through genome mapping platform	Technology Services
Mindimmune Therapeutics, Inc. Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system	Health Technology